These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3539066)

  • 1. Blocking of antibody passive hemagglutination reaction (Bl-AbHAp) as a test for in vitro recognition of type-specific soluble antigens of Clostridium botulinum.
    Ligieza J; Reiss J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):183-7. PubMed ID: 3539066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic hemagglutination inhibition test in examining of the culture supernatants of Clostridium botulinum types A, B, E, and F and some related bacterial species.
    Reiss J; Wojtyła B; Lipko A
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):531-9. PubMed ID: 6200089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemiluminescence immunosorbent assay (CLISA) and a possibility of the specific detection of soluble antigens of Clostridium botulinum type A.
    Ligieza J; Reiss J; Michalik M
    Arch Immunol Ther Exp (Warsz); 1994; 42(2):129-33. PubMed ID: 7503646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of the reversed passive hemagglutination in detection of Clostridium botulinum type A, B, and E toxin (author's transl)].
    Sonnenschein B
    Zentralbl Bakteriol Orig A; 1978 Apr; 240(2):221-34. PubMed ID: 207051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of soluble antigens of Clostridium botulinum A by chemiluminescent--immunosorbent assay (CLISA).
    Ligieza J; Michalik M; Reiss J; Grzybowski J
    Arch Immunol Ther Exp (Warsz); 1986; 34(2):189-95. PubMed ID: 2431667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insoluble antigens in the identification of Cl. botulinum. II. Agglutination and hemagglutination studies and complement fixation reaction].
    Cygan Z
    Pol Arch Weter; 1973; 16(1):47-64. PubMed ID: 4132768
    [No Abstract]   [Full Text] [Related]  

  • 7. [Problem of non-soluble antigens in the identification of Cl. botulinum. I. Precipitation and immunofluorescence studies].
    Cygan Z
    Pol Arch Weter; 1972; 15(2):245-64. PubMed ID: 4572437
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of botulinum toxin type by the reaction of indirect hemagglutination inhibition.
    Reiss J; Wojtyła B
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):97-108. PubMed ID: 7025794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.
    Sakaguchi G; Sakaguchi S; Kozaki S; Sugii S; Oishi I
    Jpn J Med Sci Biol; 1974 Jun; 27(3):161-72. PubMed ID: 4604281
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of the passive hemagglutination inhibition reaction for the purpose of determining the antigenic activity of anatoxins in vitro].
    Vorontsov IV; Moshiashvili IIa; Severtsova MK; Besova SA
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Apr; (4):62-6. PubMed ID: 375637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Isolation and immunochemical study of the toxic complex of Cl. botulinum type F].
    Blagoveshchenskiĭ VA; Nikitina AA; Khatuntseva NV; Mironova MV; Mikheeva GV
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Dec; (12):28-32. PubMed ID: 117654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of the serodiagnostic reactions of the bacterium Clostridium butyricum strain CNRZ 528 using passive hemagglutination].
    Prösch S; Benedix A
    Allerg Immunol (Leipz); 1982; 28(4):260-71. PubMed ID: 6219561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of soluble antigens by the reverse passive haemagglutination assay.
    Radu I; Mihalache D
    Roum Arch Microbiol Immunol; 1992; 51(4):205-11. PubMed ID: 1304825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Insoluble antigens in the identification of Cl. botulinum. 3. Chemical studies of polysaccharides].
    Cygan Z
    Pol Arch Weter; 1973; 16(1):65-83. PubMed ID: 4596012
    [No Abstract]   [Full Text] [Related]  

  • 15. [Determination of Clostridium boltulinum toxins using passive hemagglutination].
    Franke F
    Zentralbl Veterinarmed B; 1974 Sep; 21(9):660-76. PubMed ID: 4619737
    [No Abstract]   [Full Text] [Related]  

  • 16. [A simplified method of rapid hemagglutination test for determining the levels of tetanus antibodies].
    Reiss J; Zawistowska-Marciniak I; Grzybowski J
    Med Dosw Mikrobiol; 1991; 43(1-2):51-4. PubMed ID: 1784138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on receptor specific proteins. II. Haemagglutination and haemagglutination-inhibition reactions of Clostridium botulinum types A, C, D and E haemagglutinins.
    Balding P; Gold ER; Boroff DA; Roberts TA
    Immunology; 1973 Nov; 25(5):773-82. PubMed ID: 4586739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

  • 19. [Passive hemagglutination reaction in differentiating foot-and-mouth disease viruses].
    Tekerlekov P; Veleva E
    Vet Med Nauki; 1983; 20(3-4):7-13. PubMed ID: 6312672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indirect (passive) haemagglutination test for assay of antigen and antibody (a review).
    Gupta RK; Sharma SB; Ahuja S; Saxena SN
    Acta Microbiol Hung; 1991; 38(2):81-90. PubMed ID: 1805503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.